Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2014

01-07-2014 | Article

A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm

Authors: S. Lencot, B. Cabaret, G. Sauvage, C. Laurans, E. Launay, J.-L. Orsonneau, J. Caillon, C. Boscher, J.-C. Roze, C. Gras-Le Guen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2014

Login to get access

Abstract

Diagnostic of early-onset neonatal infection (EONI) remains an emergency. Recent studies underline the potential benefit of using Procalcitonin (PCT) in early diagnosis of bacterial infections in neonates. The aim of this study was to evaluate the diagnostic value of an umbilical blood cord PCT based algorithm in newborns suspected of EONI. The diagnostic value of the PCT based algorithm was compared to the French one currently in use by analyzing an 18-months database of newborns suspected of EONI in University Hospital of Nantes from March 2011 to September 2012. Among the 2,408 (40.8 %) newborns suspected of infection during this period, 2,366 were included in the study. The incidence of EONI was 3.4‰ (n = 20). There was no significant difference between the sensibilities of the PCT based algorithm and the current algorithm (90 %, respectively, 95%CI 76.9–100 versus 85.4–100; p = 0.90) and between their specificities (respectively 91.7 % (90.6–92.8) versus 87.4 % (86–88.7); p = 0.25). The antibiotic treatment rate would be significantly reduced with the PCT based algorithm [211 i.e. 8.9 % (7.8–10) versus 314 i.e. 13.3 % (11.9–14.7) in the current algorithm; p < 0.005] and less biological analysis would be performed [301 i.e. 12.7 % (11.4–14) versus 937 i.e. 39.6 % (37.6–41.6); p < 0.005]. Blood cord PCT seems to be a new and efficient marker to guide neonatologists taking care of newborns suspected of EONI. The PCT algorithm seems to be a safe alternative in diagnosis of EONI, allowing detection of EONI significantly as well as the current algorithm, without resulting in a substantially higher number of missed infections. These results have to be confirmed by a multicentric validation study.
Literature
2.
go back to reference Seale AC, Mwaniki M, Newton CR, Berkley JA (2009) Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis 9(7):428–438PubMedCrossRefPubMedCentral Seale AC, Mwaniki M, Newton CR, Berkley JA (2009) Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis 9(7):428–438PubMedCrossRefPubMedCentral
3.
go back to reference Koenig JM, Keenan WJ (2009) Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin N Am 56(3):689–708CrossRef Koenig JM, Keenan WJ (2009) Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin N Am 56(3):689–708CrossRef
4.
go back to reference CDC (2009) Trends in perinatal group B streptococcal disease—United States, 2000–2006. MMWR 58(5):109–112 CDC (2009) Trends in perinatal group B streptococcal disease—United States, 2000–2006. MMWR 58(5):109–112
5.
go back to reference Schrag S, Gorwitz R, Schuchat A (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51(RR-11):1–22PubMed Schrag S, Gorwitz R, Schuchat A (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51(RR-11):1–22PubMed
6.
go back to reference Verani JR, McGee L, Schrag SJ (2010) Prevention of perinatal group B streptococcal disease—revised guidelines from CDC. MMWR Recomm Rep 59(RR-10):1–36PubMed Verani JR, McGee L, Schrag SJ (2010) Prevention of perinatal group B streptococcal disease—revised guidelines from CDC. MMWR Recomm Rep 59(RR-10):1–36PubMed
7.
go back to reference Puopolo KM, Madoff LC, Eichenwald EC (2005) Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115(5):1240–1246PubMedCrossRef Puopolo KM, Madoff LC, Eichenwald EC (2005) Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115(5):1240–1246PubMedCrossRef
8.
go back to reference ANAES (2001) Prévention anténatale du risque infectieux bactérien néonatal précoce. ANAES, Haute Autorité de santé, France ANAES (2001) Prévention anténatale du risque infectieux bactérien néonatal précoce. ANAES, Haute Autorité de santé, France
9.
go back to reference ANAES (2002) Diagnostic et traitement curatif de l’infection bactérienne précoce du nouveau-né. ANAES, Haute Autorité de santé, France ANAES (2002) Diagnostic et traitement curatif de l’infection bactérienne précoce du nouveau-né. ANAES, Haute Autorité de santé, France
11.
go back to reference Sadeghi K, Berger A, Langgartner M et al (2007) Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195(2):296–302PubMedCrossRef Sadeghi K, Berger A, Langgartner M et al (2007) Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195(2):296–302PubMedCrossRef
12.
go back to reference Polin RA, Committee on Fetus and Newborn (2012) Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129(5):1006–1015PubMedCrossRef Polin RA, Committee on Fetus and Newborn (2012) Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129(5):1006–1015PubMedCrossRef
15.
go back to reference Didier C, Kuhn P (2012) Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr 171:681–687PubMedCrossRef Didier C, Kuhn P (2012) Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr 171:681–687PubMedCrossRef
16.
go back to reference Cotten CM, Taylor S, Benjamin DK Jr et al (2009) Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123(1):58–66PubMedCrossRefPubMedCentral Cotten CM, Taylor S, Benjamin DK Jr et al (2009) Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123(1):58–66PubMedCrossRefPubMedCentral
17.
go back to reference Neu J (2007) Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 65(6 Pt 1):282–285PubMedCrossRef Neu J (2007) Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 65(6 Pt 1):282–285PubMedCrossRef
18.
go back to reference Penders J, Thijs C, van den Brandt PA et al (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56(5):661–667PubMedCrossRefPubMedCentral Penders J, Thijs C, van den Brandt PA et al (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56(5):661–667PubMedCrossRefPubMedCentral
19.
go back to reference Russell SL, Finlay BB (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep, Canada Russell SL, Finlay BB (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep, Canada
20.
go back to reference Schuetz P, Christ-Crain M, Thomann R et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef Schuetz P, Christ-Crain M, Thomann R et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef
21.
go back to reference Berg P, Lindhardt BØ (2012) The role of procalcitonin in adult patients with community-acquired pneumonia—a systematic review. Dan Med J 59(3):A4357PubMed Berg P, Lindhardt BØ (2012) The role of procalcitonin in adult patients with community-acquired pneumonia—a systematic review. Dan Med J 59(3):A4357PubMed
22.
go back to reference Maniaci V, Dauber A, Weiss S et al (2008) Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 122(4):701–710PubMedCrossRef Maniaci V, Dauber A, Weiss S et al (2008) Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 122(4):701–710PubMedCrossRef
23.
go back to reference Fioretto JR, Borin FC, Bonatto RC et al (2007) Procalcitonin in children with sepsis and septic shock. J Pediatr (Rio J) 83(4):323–328CrossRef Fioretto JR, Borin FC, Bonatto RC et al (2007) Procalcitonin in children with sepsis and septic shock. J Pediatr (Rio J) 83(4):323–328CrossRef
24.
go back to reference Gomez B, Bressan S et al (2012) Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics 130(5):815–822PubMedCrossRef Gomez B, Bressan S et al (2012) Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics 130(5):815–822PubMedCrossRef
25.
go back to reference Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39(2):206–217PubMedCrossRef Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39(2):206–217PubMedCrossRef
26.
go back to reference Gendrel D, Assicot M, Raymond J et al (1996) Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128(4):570–573PubMedCrossRef Gendrel D, Assicot M, Raymond J et al (1996) Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128(4):570–573PubMedCrossRef
27.
go back to reference Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4(10):620–630PubMedCrossRef Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4(10):620–630PubMedCrossRef
28.
go back to reference Vouloumanou EK, Plessa E, Karageorgopoulos DE et al (2011) Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 37(5):747–762PubMedCrossRef Vouloumanou EK, Plessa E, Karageorgopoulos DE et al (2011) Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 37(5):747–762PubMedCrossRef
29.
go back to reference Chiesa C, Pellegrini G et al (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49(1):60–68PubMedCrossRef Chiesa C, Pellegrini G et al (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49(1):60–68PubMedCrossRef
30.
go back to reference Vazzalwar R, Pina-Rodrigues E, Puppala BL et al (2005) Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J Perinatol 25(6):397–402PubMedCrossRef Vazzalwar R, Pina-Rodrigues E, Puppala BL et al (2005) Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J Perinatol 25(6):397–402PubMedCrossRef
31.
go back to reference Turner D, Hammerman C, Rudensky B et al (2006) Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 91(4):F283–F286PubMedCrossRefPubMedCentral Turner D, Hammerman C, Rudensky B et al (2006) Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 91(4):F283–F286PubMedCrossRefPubMedCentral
32.
go back to reference Lopez Sastre JB, Solis DP, Serradilla VR et al (2007) Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr 7:9PubMedCrossRefPubMedCentral Lopez Sastre JB, Solis DP, Serradilla VR et al (2007) Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr 7:9PubMedCrossRefPubMedCentral
33.
go back to reference Chiesa C, Panero A, Rossi N et al (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26(3):664–672PubMedCrossRef Chiesa C, Panero A, Rossi N et al (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26(3):664–672PubMedCrossRef
34.
go back to reference Joram N, Muller JB, Denizot S (2011) Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study. Eur J Clin Microbiol Infect Dis 30:1005–1013PubMedCrossRef Joram N, Muller JB, Denizot S (2011) Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study. Eur J Clin Microbiol Infect Dis 30:1005–1013PubMedCrossRef
35.
go back to reference Joram N, Boscher C, Denizot S et al (2006) Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonatal Ed 91(1):F65–F66PubMedCrossRefPubMedCentral Joram N, Boscher C, Denizot S et al (2006) Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonatal Ed 91(1):F65–F66PubMedCrossRefPubMedCentral
36.
go back to reference Kordek A, Hałasa M, Podraza W (2008) Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood. Clin Chem Lab Med 46(8):1143–1148PubMedCrossRef Kordek A, Hałasa M, Podraza W (2008) Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood. Clin Chem Lab Med 46(8):1143–1148PubMedCrossRef
37.
go back to reference National Collaborating Centre for Women's and Children's Health (UK) (2012) Antibiotics for early-onset neonatal infection. National Institute for Health and Clinical Excellence, RCOG Press, London National Collaborating Centre for Women's and Children's Health (UK) (2012) Antibiotics for early-onset neonatal infection. National Institute for Health and Clinical Excellence, RCOG Press, London
38.
go back to reference Haque KN (2005) Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 6(3 Suppl):S45–S49PubMedCrossRef Haque KN (2005) Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 6(3 Suppl):S45–S49PubMedCrossRef
39.
go back to reference Hofer N, Müller W, Resch B (2011) Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life. Clin Chem Lab Med 49(2):297–302PubMedCrossRef Hofer N, Müller W, Resch B (2011) Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life. Clin Chem Lab Med 49(2):297–302PubMedCrossRef
40.
go back to reference Mims LC, Medawar MS, Grubb WR et al (1972) Predicting neonatal infections by evaluation of the gastric aspirate: a study in two hundred and seven patients. Am J Obstet Gynecol 114(2):232–238PubMed Mims LC, Medawar MS, Grubb WR et al (1972) Predicting neonatal infections by evaluation of the gastric aspirate: a study in two hundred and seven patients. Am J Obstet Gynecol 114(2):232–238PubMed
Metadata
Title
A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm
Authors
S. Lencot
B. Cabaret
G. Sauvage
C. Laurans
E. Launay
J.-L. Orsonneau
J. Caillon
C. Boscher
J.-C. Roze
C. Gras-Le Guen
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2065-3

Other articles of this Issue 7/2014

European Journal of Clinical Microbiology & Infectious Diseases 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.